Posts Tagged ‘abbvie’

Here’s how AbbVie gamed the U.S. patent system to generate $114 billion in revenues from Humira drug

(NaturalNews) (Natural News) Since 2016, pharmaceutical giant AbbVie has generated more than $114 billion in revenue from the sale of its anti-inflammatory drug Humira. That same year, Humira was supposed to go off-patent and become generic – meaning it would have cost a whole lot less for consumers – but because of patent manipulation, AbbVie […]

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes